-
Categories
When you compare Nalena vs MEDVi, you’ll find both telehealth platforms make GLP-1 weight-loss medications like semaglutide and tirzepatide accessible from home. Each offers online consultations, prescription management, and direct-to-door shipping, but they take different routes when it comes to pricing transparency, hormone-focused care, and patient support. Understanding those distinctions can help you choose the program that fits your needs and budget.
Nalena, launched in 2026, zeroes in on women experiencing hormonal shifts during perimenopause, menopause, and postmenopause. MEDVi, on the other hand, provides broad access to GLP-1 therapies with round-the-clock specialist support since its debut in 2024.